Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -33.27%365M | -67.73%272M | 148.15%871M | -22.43%1.04B | -230.84%-700M | 59.01%547M | 553.23%843M | -45.92%351M | 118.92%1.34B | 29.54%535M |
| Net income from continuing operations | 23.39%480M | 39.10%370M | -20.98%241M | 22.78%1.23B | -19.22%269M | 463.77%389M | 8.57%266M | -13.84%305M | 186.82%1B | 45.41%333M |
| Unrealized gains and losses of investment securities | 68.32%-511M | 90.52%623M | -92.93%80M | 111.57%234M | 110.06%389M | -153.20%-1.61B | 379.49%327M | 205.70%1.13B | -119.94%-2.02B | -1,738.56%-3.87B |
| Interest credited to policyholders’ deposits | -5.56%17M | 0.00%17M | 5.88%18M | 1.52%67M | 0.00%15M | -5.26%18M | 21.43%17M | -5.56%17M | 15.79%66M | -6.25%15M |
| Other non cash items | -84.06%247M | -332.19%-1.26B | 130.67%341M | -318.70%-2.06B | -192.53%-2.21B | 164.96%1.55B | 82.79%-292M | -192.13%-1.11B | 95.67%-492M | 407.61%2.38B |
| Change in working capital | 5.47%270M | -28.17%408M | 195.70%275M | -36.98%1.76B | -52.35%842M | 158.72%256M | -57.89%568M | -16.22%93M | 94.22%2.79B | 157.96%1.77B |
| -Change in loss and loss adjustment expense reserves | ---- | -173.53%-50M | 68.75%108M | -100.97%-15M | ---- | ---- | --68M | --64M | --1.55B | ---- |
| -Change in other working capital | -15.46%328M | -8.40%458M | 475.86%167M | 42.83%1.77B | 293.12%857M | 45.86%388M | -22.72%500M | -73.87%29M | -13.57%1.24B | -68.18%218M |
| Tax refund paid | -65.69%-227M | 123.73%28M | -6.92%-170M | -73.38%-508M | 45.98%-94M | -953.85%-137M | -76.12%-118M | -307.69%-159M | -11.83%-293M | -314.29%-174M |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | -33.27%365M | -67.73%272M | 148.15%871M | -22.43%1.04B | -230.84%-700M | 59.01%547M | 553.23%843M | -45.92%351M | 118.92%1.34B | 29.54%535M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 30.68%-61M | 81.09%-52M | -75.86%-102M | -59.93%-491M | -1.45%-70M | -23.94%-88M | -166.99%-275M | 9.38%-58M | -6.97%-307M | 12.66%-69M |
| Net PPE purchase and sale | 30.68%-61M | 16.13%-52M | 13.79%-50M | 0.36%-278M | -1.45%-70M | -23.94%-88M | 17.33%-62M | 9.38%-58M | 2.79%-279M | 12.66%-69M |
| Net business purchase and sale | --0 | --0 | ---52M | -660.71%-213M | --0 | --0 | ---213M | --0 | ---28M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 30.68%-61M | 81.09%-52M | -75.86%-102M | -59.93%-491M | -1.45%-70M | -23.94%-88M | -166.99%-275M | 9.38%-58M | -6.97%-307M | 12.66%-69M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 44.22%-193M | 562.22%208M | -148.62%-542M | 60.65%-397M | 178.23%212M | 42.33%-346M | -120.74%-45M | 38.59%-218M | -92.19%-1.01B | -90.85%-271M |
| Net issuance payments of debt | 98.57%-5M | -101.49%-5M | -8,000.00%-405M | 1,800.00%374M | 9,925.00%393M | 13.58%-350M | -14.07%336M | -25.00%-5M | -178.57%-22M | 20.00%-4M |
| Net common stock issuance | -131.74%-73M | 75.00%-70M | 78.95%-24M | 46.67%-240M | 55.03%-76M | 350.00%230M | -233.33%-280M | -8.57%-114M | -1,018.37%-450M | -231.37%-169M |
| Net preferred stock issuance | --0 | ---- | ---- | 16.67%-125M | --0 | ---125M | --0 | --0 | 40.00%-150M | --0 |
| Cash dividends paid | -22.62%-103M | -3.37%-92M | -17.07%-96M | -6.10%-348M | -6.90%-93M | -6.33%-84M | 0.00%-89M | -12.33%-82M | -7.89%-328M | -3.57%-87M |
| Interest paid (cash flow from financing activities) | 29.41%-12M | -66.67%-20M | 0.00%-17M | 1.69%-58M | -9.09%-12M | 29.17%-17M | -1,100.00%-12M | 26.09%-17M | -22.92%-59M | -450.00%-11M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 44.22%-193M | 562.22%208M | -148.62%-542M | 60.65%-397M | 178.23%212M | 42.33%-346M | -120.74%-45M | 38.59%-218M | -92.19%-1.01B | -90.85%-271M |
| Net cash flow | ||||||||||
| Beginning cash position | 10.90%2.21B | 22.71%1.79B | 13.56%1.57B | 1.55%1.38B | 76.22%2.1B | 31.61%1.99B | -7.99%1.46B | 1.55%1.38B | -12.16%1.36B | 1.97%1.19B |
| Current changes in cash | -1.77%111M | -18.16%428M | 202.67%227M | 488.46%153M | -386.15%-558M | 134.56%113M | 826.39%523M | -67.39%75M | 113.07%26M | 1.56%195M |
| Effect of exchange rate changes | 200.00%6M | -400.00%-15M | -87.50%1M | 780.00%34M | 550.00%27M | -220.00%-6M | 200.00%5M | 700.00%8M | -145.45%-5M | -500.00%-6M |
| End cash Position | 10.82%2.32B | 10.90%2.21B | 22.71%1.79B | 13.56%1.57B | 13.56%1.57B | 76.22%2.1B | 31.61%1.99B | -7.99%1.46B | 1.55%1.38B | 1.55%1.38B |
| Free cash flow | -33.77%304M | -71.83%220M | 180.20%821M | -28.22%763M | -265.24%-770M | 68.13%459M | 399.23%781M | -49.91%293M | 226.07%1.06B | 39.52%466M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.